Therapeutic Asset Ratings
705 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Romidepsin
Telomere Biology Disorder
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Romidepsin
TP53
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
TACROLIMUS
Transplant Rejection
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
TACROLIMUS
Natural Killer Cell Malignancies
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Acyl-CoA Oxidase Deficiency
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Adrenoleukodystrophy With Cerebral Involvement
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Alpha-methylacyl-CoA Racmase Deficiency
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Aspartylglucosaminuria
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
D-Bifunctional Enzyme Deficiency
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Fucosidosis
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Globoid Cell Leukodystrophy
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Glycoprotein Metabolic Disorders
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation)
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Hunter Syndrome
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Infantile Refsum Disease
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Maroteaux Lamy Syndrome
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Metachromatic Leukodystrophy
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Mitochondrial Neurogastrointestingal Encephalopathy
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Mucopolysaccharidosis Disorders
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Multifunctional Enzyme Deficiency
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Neonatal Adrenoleukodystrophy
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Niemann-Pick B
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Niemann-Pick C Subtype 2
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Peroxisomal Disorders
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Thiotepa
Recessive Leukodystrophies
Masonic Cancer Center, University of Minnesota
P2
CCC
(53)
Showing 526 to 550 of 705 assets
Previous
Page 22 of 29
Next